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Abstract
We encountered a very rare case of bile duct carcinoma associated with congenital biliary dilatation (CBD) in a
16-year-old female who was admitted to our hospital because of right upper abdominal pain and vomiting.
Abdominal computed tomography demonstrated a cystic dilatation of the common bile duct measuring 7 cm in
diameter and two enhanced tumors 4 cm in diameter located in the inferior bile duct and middle bile duct.
Magnetic resonance cholangiopancreatography clearly demonstrated a cystic dilatation of the extrahepatic bile
duct (Todani’s CBD classification: type 4-A). Endoscopic retrograde cholangiopancreatography also revealed two
tumors. Biopsy results of one of the tumors confirmed adenocarcinoma. Excision of the perihilar bile duct and
subtotal stomach-preserving pancreaticoduodenectomy with dissection of the major lymph nodes were performed.
A postoperative histopathologic examination revealed a well-differentiated tubular adenocarcinoma, which
remained within the mucosal layer, and no lymph node metastasis was found. The postoperative course was
uneventful, and the patient was discharged 10 days after surgery and has remained disease-free for 21 months.
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Background
It is well known that congenital biliary dilatation (CBD)
has a significant association with bile duct carcinoma
and that CBD merges with pancreaticobiliary maljunc-
tion (PBM) in all cases [1]. PBM is a congenital anomaly
defined as a junction of the pancreatic and biliary ducts
located outside of the duodenal wall that usually forms a
markedly long common channel [2, 3]. Some authors
have proposed a hyperplasia-dysplasia-carcinoma se-
quence [4, 5]. Thus, PBM is thought to be a high risk
factor for the development of carcinoma in the biliary
tract. Here, we report a rare case of a 16-year-old female
with early bile duct carcinoma combined with PBM and
CBD.
Case presentation
A 16-year-old female was admitted to our hospital with
a chief complaint of right upper abdominal pain and
vomiting. Although our patient was autistic, her condi-
tion did not play any role in her present illness. Her
body mass index was 18.49. Her family history included
a grandfather treated for colon cancer at an unknown
age, but there was no family history of anomalies of the
pancreaticobiliary tract system. On physical examination,
there was slight tenderness and an abnormal palatable
mass in the right upper abdomen. Blood test findings on
admission were as follows (Table 1): mild anemia and a
longitude increase in hepatobiliary enzymes, amylase,
and elastase 1, while levels of carcinoembryonic antigen
and cancer antigen 19-9 (CA19-9) were within normal
ranges.
Abdominal ultrasonography revealed a cystic dilatation
of the extrahepatic bile duct and two protruding tumors
in the lumen of the dilated common bile duct (Fig. 1).
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Doppler ultrasound detected a blood flow signal within
the tumor. Abdominal computed tomography (Fig. 2)
demonstrated a cyst within the common bile duct
measuring 7 cm in diameter and two enhanced tumors
measuring 4 cm in diameter located in the inferior bile
duct and middle bile duct. Magnetic resonance cholan-
giopancreatography (Fig. 3) clearly demonstrated a cys-
tic dilatation of the extrahepatic bile duct (Todani’s
CBD classification: type 4-A) [1]. Endoscopic retro-
grade cholangiopancreatography (Fig. 4) also demon-
strated a cystic dilatation of the bile duct as well as the
presence of two tumors. Biopsy of one of the tumors
confirmed the presence of adenocarcinoma. Amylase,
CA19-9, and carcinoembryonic antigen levels in the
choledochal cyst were 54,722 IU/l, 230,853 U/ml, and
3.051 ng/ml, respectively.
At laparotomy, the cystic common bile duct was easily
found. The wall of the bile duct had no indurations or
scaring. Excision of the perihilar bile duct and subtotal
stomach-preserving pancreaticoduodenectomy (SSPPD)
with dissection of the major lymph nodes were per-
formed. The proximal stump of the choledochus was
negative for malignant cells.
The resected specimen demonstrated tumors in the in-
ferior and middle bile ducts (Fig. 5). Immunostaining was
positive for CDX2 and negative for MUC1, MUC2,
MUC5AC, MUC6, and p53. According to the Union for
International Cancer Control (UICC), sixth edition rules,
this case was stage 0 (Tis, N0, and M0). A postoperative
histopathologic examination revealed a well-differentiated
tubular adenocarcinoma, which entirely remained within
the mucosal layer, and no lymph node metastasis was
found (Fig. 6). The postoperative course was uneventful,
and the patient was discharged 10 days after surgery and
has remained disease-free for 21 months.
Table 1 Blood test findings on admission
Level Units
WBC 4.9 × 103 /μl
RBC 4.48 × 106 /μl
Hb 10.5 g/dl
Ht 33.2 %



















Elastase 1 437 ng/dl
Fig. 1 Abdominal ultrasonography showed two tumors extending into the common bile duct. Doppler ultrasound showed a blood flow signal
within the tumor
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Discussion
The disease concept of CBD and classification according
to morphological features was first described by Alonso-
Lej et al. in 1959 [6]. It is well known that CBD merges
with PBM in all cases. PBM is a congenital anomaly
defined as a junction of the pancreatic and biliary ducts
located outside of the duodenal wall that usually forms a
markedly long common channel [2, 3]. As the action of
the sphincter of Oddi does not functionally affect this
union, two-way regurgitation (biliopancreatic and pan-
creatobiliary reflux) occurs, resulting in various patho-
logical conditions in the biliary tract and pancreas [7, 8].
PBM, particularly in Asian patients, is a well-known risk
factor for the development of carcinoma in the biliary
tract [9]. According to a report by Todani et al. [10], the
mean patient age for carcinoma arising in a choledochal
cyst is 37 years (range, 15–73 years). Therefore, ad-
vanced biliary tract carcinoma in teenage patients is rela-
tively uncommon.
A MEDLINE literature search of English language
articles revealed only six cases of biliary tract carcin-
oma in patients with PBM or CBD younger than
20 years (Table 2) [11–16]. Of these six patients, half
were male and the most common PBM subtype was
C-P, in which the common bile duct joins the major
pancreatic duct. According to the classification of
Todani [17], two patients had type 1a disease and two
had type 4-A disease. The most common histological
type of cancer was adenocarcinoma, and four cases
underwent complete tumor resection of the choledo-
chal cyst.
Fig. 3 Magnetic resonance cholangiopancreatography demonstrated
a cystic dilatation of the extrahepatic bile duct (Todani’s CBD
classification: type 4-A)
Fig. 4 Endoscopic retrograde cholangiopancreatography showed
two tumors, and biopsy of one of the tumors
confirmed adenocarcinoma
Fig. 2 Abdominal CT showed two enhanced tumors (diameter, 4 cm)
in the inferior and middle bile duct. Yellow arrows indicate the
tumor locations
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In the present case, the bile amylase level in the com-
mon bile duct was 54,722 IU/l, so chronic inflammation
leading to malignant change was observed. This high
amylase level in the choledochal cyst suggested a free re-
flux of pancreatic juice into the biliary system that might
have caused chronic inflammation in the choledochal
cyst [18]. The carcinogenesis of CBD coexisting with
PBM is considered to involve the hyperplasia-dysplasia-
carcinoma sequence provoked by chronic inflammation
resulting from a reflux of pancreatic juices into the bil-
iary tract [4, 5]. Strong cytotoxic substances are pro-
duced when phospholipase A2 in the pancreatic juice
mixes with bile, which have been recognized both clinic-
ally and experimentally to be injurious to cell mem-
branes. Moreover, the subsequent chronic inflammation
provokes high proliferative activity in the mucosal epi-
thelia, finally resulting in CBD in PBM patients [19].
Once a diagnosis of CBD is made, early radical surgery
for CBD combined with thorough intraoperative histo-
pathologic examinations may be necessary, irrespective
of the patient’s age. A preoperative diagnosis of bile duct
carcinoma in CBD is sometimes difficult to establish
[16]. In our case, the enhanced huge tumor in the di-
lated choledochus on CT was an important clue for the
diagnosis of malignancy in CBD. The carcinoma spread
to the level of the bile duct in the pancreas; therefore,
after additional excision of the perihilar bile duct, SSPPD
was performed. The surgical procedure should be modi-
fied based on the spread of the carcinoma because rad-
ical resection appears to be the only chance of cure in
such cases.
Fig. 6 a, b Pathological examination revealed a well-differentiated tubular adenocarcinoma in the inferior bile duct (a) (hematoxylin and eosin
(H.E., ×120) and middle bile duct (b) (H.E., ×120)
Fig. 5 The resected specimen demonstrated tumors in the inferior
and middle bile ducts. Arrow indicates the papilla of Vater
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Conclusions
We encountered a case of bile duct carcinoma in a 16-
year-old female with PBM and CBD. The incidence of
cancer in young people with CBD is very low; however,
CBD can become cancerous after a long period of time
has elapsed. Therefore, at the time of diagnosis of CBD,
a preoperative inspection for bile duct carcinoma may
be necessary.
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